Royalty Pharma holder plans sale of 11,002 shares

TPC RP EPA1 LLC, an affiliate stockholder of Royalty Pharma plc (symbol RPRX), filed a notice of proposed sale of 11,002 shares of common stock through Goldman Sachs & Co. LLC.

Rhea-AI Filing Summary

TPC RP EPA1 LLC, an affiliate stockholder of Royalty Pharma plc (symbol RPRX), filed a notice of proposed sale of 11,002 shares of common stock through Goldman Sachs & Co. LLC. The shares were acquired on 08/05/2026 as compensation under performance awards from the issuer.

The filing also lists a prior transaction in the last three months, where TPC RP EPA1 LLC sold 64,399 shares of common stock on 05/26/2026 for an aggregate amount of $3,476,118.96.

Key Figures

Shares proposed for sale: 11,002 shares of common stock Shares sold in past 3 months: 64,399 shares of common stock Aggregate amount from prior sale: $3,476,118.96 +2 more

5 metrics

Shares proposed for sale 11,002 shares of common stock Securities to be sold as listed in the Form 144 notice

Shares sold in past 3 months 64,399 shares of common stock Securities sold on 05/26/2026 during the past 3 months

Aggregate amount from prior sale $3,476,118.96 Aggregate amount for 64,399 shares sold on 05/26/2026

Acquisition date of compensation shares 08/05/2026 Date 11,002 shares were acquired as compensation via performance awards

Planned sale reference date 08/13/2026 Date associated with common stock entry and NASD trading line

Key Terms

Securities To Be Sold, Securities Sold During The Past 3 Months, Performance Awards

3 terms

Securities To Be Sold regulatory

"144: Securities To Be Sold Common Stock | 08/05/2026 | Acquired as compensation"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months TPC RP EPA1 LLC 110 East 59th Street"

Performance Awards financial

"Acquired as compensation -- Performance Awards | The Issuer | | | 11002"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is TPC RP EPA1 LLC planning for RPRX under this Form 144?

TPC RP EPA1 LLC filed to potentially sell 11,002 shares of Royalty Pharma (RPRX) common stock. The notice lists Goldman Sachs & Co. LLC as broker and identifies the shares as acquired as compensation via performance awards on 08/05/2026.

How many RPRX shares did TPC RP EPA1 LLC sell in the last three months?

The filing reports that TPC RP EPA1 LLC sold 64,399 shares of RPRX common stock on 05/26/2026. The aggregate sale amount for this transaction is disclosed as $3,476,118.96.

How were the RPRX shares to be sold by TPC RP EPA1 LLC acquired?

The 11,002 RPRX shares proposed for sale were acquired as compensation on 08/05/2026. The filing specifies they came from performance awards granted by the issuer as part of compensation.

Which broker is handling the proposed RPRX share sale for TPC RP EPA1 LLC?

The proposed sale of 11,002 RPRX common shares will be handled by Goldman Sachs & Co. LLC. The broker’s address is listed as 200 West Street, New York, NY 10282, with trading noted on NASD.

What is the aggregate dollar value disclosed for recent RPRX stock sales?

For the sale on 05/26/2026, TPC RP EPA1 LLC reports an aggregate amount of $3,476,118.96. This corresponds to the disposition of 64,399 RPRX common shares during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:44 PM Accepted by SEC EDGAR 08/13/2026 - 04:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001814876
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Royalty Pharma plc
SEC File Number	001-39329
Address of Issuer	110 East 59th Street New York NEW YORK 10022
Phone	1-212-883-0200
Name of Person for Whose Account the Securities are To Be Sold	Terrance Coyne
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	11002	644277.12	445277344	08/13/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/05/2026	Acquired as compensation -- Performance Awards	The Issuer			11002	08/05/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TPC RP EPA1 LLC 110 East 59th Street New York NY 10022	Common Stock	05/26/2026	64399	3476118.96

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 2/24/2026, that is intended to comply with Rule 10b5-1(c). 11,002 shares to be sold by TPC RP EPA1 LLC.
Date of Notice	08/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Terrance Coyne
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)